Phase II study of aziridinylbenzoquinone (AZQ) in patients with central nervous system malignancies: a Southwest Oncology Group Study. [electronic resource]
Producer: 19851015Description: 131-5 p. digitalISSN:- 0167-594X
- Adult
- Aged
- Aziridines -- therapeutic use
- Azirines -- toxicity
- Benzoquinones
- Brain Neoplasms -- drug therapy
- Cerebellar Neoplasms -- drug therapy
- Cyclohexenes
- Drug Evaluation
- Ependymoma -- drug therapy
- Female
- Glioblastoma -- drug therapy
- Humans
- Male
- Medulloblastoma -- drug therapy
- Middle Aged
- Neoplasm Staging
- Oligodendroglioma -- drug therapy
- Risk
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.